Personalized Cell Therapy Market

The patient-tailored therapies for the treatment of variety of disease are known as personalized cell therapy. The personalized cell therapy is based on genomic profile, and disease prevalence/severity and the drug developed by this therapy target the patients who matches the specific disease physiopathology and/or patient characteristics.The personalized cell therapy is mainly developed for the treatment of high unmet need disease

Personalized Cell Therapy Market contains market size and forecasts of Personalized Cell Therapy in Global, including the following market information:

• Global Personalized Cell Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Personalized Cell Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

By Cell Type Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Personalized Cell Therapy include Novartis AG, Vericel Corporation, Bellicum Pharmaceuticals, MolMed SpA, Cytori Therapeutics Inc, Gilead Sciences, Inc, Celgene Corporation, Bluebird Bio and Aurora Biopharma Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Personalized Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Personalized Cell Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Personalized Cell Therapy Market Segment Percentages, by Type, 2021 (%)

By Cell Type

• Hematopoietic Stem Cell
• Skeletal Muscle Stem Cell
• Mesenchymal Stem Cells
• Lymphocytes
• Others

By Technique

• Platelet Transfusions
• Bone Marrow Transplantation
• Packed Red Cell Transfusions
• Organ Transplantation

Global Personalized Cell Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Personalized Cell Therapy Market Segment Percentages, by Application, 2021 (%)

• Cardiovascular Diseases
• Neurological Disorders
• Inflammatory Diseases
• Diabetes
• Cancer
• Others

Global Personalized Cell Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Personalized Cell Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Personalized Cell Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Personalized Cell Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis AG
• Vericel Corporation
• Bellicum Pharmaceuticals
• MolMed SpA
• Cytori Therapeutics Inc
• Gilead Sciences, Inc
• Celgene Corporation
• Bluebird Bio
• Aurora Biopharma Inc
• Saneron CCEL Therapeutics Inc
• Kuur Therapeutics
• MediGene AG
• Sangamo Therapeutics